Amgen’s rare-disease treatment biosimilar Bkemv gets FDA approval
Pharmaceutical regulators approved Amgen’s Bkemv, a biosimilar to rare-disease treatment Soliris.
Pharmaceutical regulators approved Amgen’s Bkemv, a biosimilar to rare-disease treatment Soliris.
Hess Corp. shareholders voted to approve a proposed $53 billion buyout by Chevron Corp., the company said late Tuesday.
Fantom partners with Google Cloud as a key node validator to boost DApp development. Google Cloud’s infrastructure and AI capabilities will enhance Fantom’s ecosystem. FTM...
Judge dismisses U.S. SEC’s case against Debt Box, orders SEC to pay $1.8 million in fees. The Ruling cites SEC’s bad faith conduct in obtaining...
American Airlines Group Inc. late Tuesday slashed its guidance for the current quarter, only one month after offering an upbeat take for the three-month period.
The road to a $3 trillion market capitalization for Nvidia might very well run through Apple.
American said it expects unit revenues to fall as much as 6% in the second quarter from a year earlier.
Tesla shareholders are being asked to vote on Chief Executive Elon Musk’s $56 billion pay package, and also decide whether the company should reincorporate in...
Shares of Robinhood Markets Inc. rose more than 5% in the extended session Tuesday after the online broker said its board approved a $1 billion...